Ludwig Lausanne’s George Coukos and Ludwig Weill Cornell’s Jedd Wolchok elected Fellows of the AACR

Ludwig Lausanne Director George Coukos and Jedd Wolchok, who is co-director of the Ludwig Collaborative Laboratory at Weill Cornell Medicine and a Member of the Board of the Ludwig Institute for Cancer Research, were elected in April as Fellows of the Academy of the American Association for Cancer Research (AACR), class of 2023. The Academy honors scientists whose research has contributed significantly to our understanding of cancer biology or fueled innovation in cancer prevention and care. Out of George’s many accomplishments, the Academy highlighted his “seminal contributions to characterizing the occurrence of spontaneous immune responses in ovarian tumors, for demonstrating that tumor infiltrating lymphocytes may function as strong predictors of enhanced ovarian cancer survival and for designing and implementing critical immunotherapy clinical trials.” Similarly, in Jedd’s case, the Academy selected from a sprawling body of notable science his “illustrious contributions to novel cancer immunotherapy strategies, such as demonstrating the benefits of checkpoint inhibitor therapy in melanoma and leading several pivotal clinical trials, including the phase I clinical trial for ipilimumab and the phase III clinical trial involving the combination of ipilimumab and nivolumab.” Nominees to the AACR Academy are elected through an annual peer review process and ratified by the Executive and other committees.